CharlesCMiragliaMD

Pathology • Indianapolis, IN

Blood Banking & Transfusion Medicine, Transplantation Immunology, Anatomic Pathology, Clinical Pathology

President & CEO, Indiana Blood Center

Join to view full profile

Dr. Miraglia is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Miraglia's full profile

Already have an account?

Office
3450 N. Meridian Street
Indianapolis, IN 46208
Phone+1 317-916-5001
Is this information wrong?

Education & Training

University of Virginia Medical CenterResidency, Pathology-Anatomic and Clinical, 1991 - 1993
University of Virginia Medical CenterInternship, Transitional Year, 1989 - 1990
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1989

Certifications & Licensure

IN State Medical License 1995 - 2025
CO State Medical License 2021 - 2025
VA State Medical License 1991 - 2016
KY State Medical License 1993 - 2011
American Board of Pathology Clinical Pathology
American Board of Pathology Blood Banking/Transfusion Medicine

Publications & Presentations

PubMed

18 citations
Thrombotic thrombocytopenic purpura: yesterday, today, tomorrow.
Leo J. McCarthy, Jeffrey S Dlott, Attilio Orazi, Daniel Waxman, Charles C. Miraglia, Constance Danielson> ;Therapeutic Apheresis and Dialysis. 2004 Apr 1
What are appropriate initial and salvage therapies for patients with thrombotic thrombocyopenic purpura (TTP)
Leo J. McCarthy, Atillio Orazi, Charles C. Miraglia, Daniel Waxman, Elaine Skipworth, Constance Danielson> ;Acta Medica. 2004 Jan 1
40 citations
Myocardial infarction/injury is relatively common at presentation of acute thrombotic thrombocytopenic purpura: the Indiana University experience.
Leo J. McCarthy, Constance Danielson, Elaine Skipworth, Shelley L. Peters, Charles C. Miraglia, Asok C. Antony> ;Therapeutic Apheresis. 2002 Feb 1
6 citations
Completely converting a blood service region to the use of safer plasma.
Leo J. McCarthy, Constance Danielson, Sandra S. Rothenberger, Carol Parker, John Weidner, Charles C. Miraglia, Deborah Matus, Dan A. Waxman> ;Transfusion. 2000 Oct 1
Chronic severe thrombotic thrombocytopenic purpura (TTP)
Leo J. McCarthy, Constance Danielson, John Weidner, Charles C. Miraglia> ;Therapeutic Apheresis. 1999 Nov 1
20 citations
Platelet membrane early activation markers during prolonged storage.
Hidehiko Matsubayashi, John Weidner, Charles C. Miraglia, John A. McIntyre> ;Thrombosis Research. 1999 Feb 15
Peripheral blood stem cell collection in a patient with chronic myelogenous leukemia and a high circulating nucleated red cell fraction
Jong-Hoon Lee, Charles C. Miraglia, William W. Grosh, Paul D. Mintz> ;Journal of Clinical Apheresis. 1995 Jan 1
5 citations
Regulation of Thrombin Cleavage of Plasma Factor XIII Bound to Fibrin
Charles S. Greenberg, Komandoor E. Achyuthan, Charles C. Miraglia, Joseph V. Dobson> ;Annals of the New York Academy of Sciences. 1986 Dec 1
2 citations
Thrombin binding to fibrin is necessary for fibrin polymers to enhance factor XIIIa formation.
Charles S. Greenberg, Komandoor E. Achyuthan, Charles C. Miraglia> ;Seminars in Thrombosis and Hemostasis. 1986 Jul 1
43 citations
Regulation of plasma factor XIII binding to fibrin in vitro
Charles S. Greenberg, Joseph V. Dobson, Charles C. Miraglia> ;Blood. 1985 Nov 1
26 citations
Antigens associated with the activation of murine mononuclear phagocytes in vivo: differential expression of lymphocyte function-associated antigen in the several stag...
Gideon Strassmann, Timothy A. Springer, Stephen Haskill, Charles C. Miraglia, Lewis L. Lanier, Dolph O. Adams> ;Cellular Immunology. 1985 Aug 1
33 citations
The effect of fibrin polymers on thrombin-catalyzed plasma factor XIIIa formation.
Charles S. Greenberg, Charles C. Miraglia> ;Blood. 1985 Aug 1
53 citations
Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
Charles S. Greenberg, Charles C. Miraglia, Frederick R. Rickles, Marc A. Shuman> ;The Journal of Clinical Investigation. 1985 May 1
30 citations
Measurement of blood coagulation Factor XIIIa formation in plasma containing glycyl-L-prolyl-L-arginyl-L-proline.
Charles C. Miraglia, Charles S. Greenberg> ;Analytical Biochemistry. 1985 Jan 1
Platelet transfusion and thrombotic thrombocytopenic purpura.
McCarthy, L. J., Danielson, C. F., Miraglia, C., Waxman, D.> ;Transfusion. 2003 Jun
20 citations
Do automated red cell exchanges relieve priapism in patients with sickle cell anemia
Leo J. McCarthy, J. Vattuone, J. Weidner, Elaine Skipworth, Christine Fernandez, L. Jackson, Sandra S. Rothenberger, Daniel Waxman, C. Miraglia, Pierluigi Porcu, Const...> ;Therapeutic Apheresis. 2000 Jun 1
Development of optimal techniques for cryopreservation of human platelets. I. Platelet activation during cold storage (at 22 and 8 degrees C) and cryopreservation.
Gao, D. Y., Neff, K., Xiao, H. Y., Matsubayashi, H., Cui, X. D., Bonderman, P., Bonderman, D., Harvey, K., McIntyre, J. A., Critser, J., Miraglia, C. C., Reid, T.> ;Cryobiology. 1999 May
Effect of freezing on the in vivo recovery of irradiated red cells.
Miraglia, C. C., Anderson, G., Mintz, P. D.> ;Transfusion. 1994 Sep
Generation of annexin V-positive platelets and shedding of microparticles with stimulus-dependent procoagulant activity during storage of platelets at 4 degrees C.
Xiao, H. Y., Matsubayashi, H., Bonderman, D. P., Bonderman, P. W., Reid, T., Miraglia, C. C., Gao, D. Y.> ;Transfusion. 2000 Apr
Join now to see all